
Nyxoahrevenue & market cap
Mont-Saint-Guibert, BelgiumFounded 2009
Public companyNyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).
Nyxoah revenue
Nyxoah's annual revenue was $11.4M in December 2025 (Stock Analysis; converted from euros).
$0
$5M
$10M
$0
–
$5.1M
$11.4M
20092010–2320242025
All 2 revenue readings, with sources
| As of | Revenue | Source |
|---|---|---|
| Dec 2024 | $5.1M | Stock Analysisconverted from euros |
| Dec 2025 | $11.4M | Stock Analysisconverted from euros |
Nyxoah market cap
Nyxoah is a public company. Its market capitalisation was $160.4M in September 2026.
Nyxoah FAQ
Categories
How this page is sourced
2 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun Nyxoah? Join the podcast